8
Oct
2024

Laboratorios Salvat, S.A.

Exhibitor at CPHI Milan 2024 stand 14F20, Finished Dosage Formulations
About Us

Salvat is a global pharmaceutical company focused on ophthalmology, otolaryngology, gastroenterology, and wound care Rx and OTC products. Specializing in Sterile Liquid CDMO services (Multi-dose and Single-dose vials with BFS technology).
For over 65 years, Salvat has been developing, manufacturing, and marketing pharmaceutical products successfully in over 60 countries. 

Headquartered in Barcelona, Spain with a US subsidiary in Miami, FL.

  • ES
  • 2016
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Drug delivery device Supplier/Manufacturer
Licensee
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 14F20, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • SVT-15473 -  Inflammation and pain after ocular surgery - Clobetasol 0.05% nanoemulsion Rx

    Product SVT-15473 - Inflammation and pain after ocular surgery - Clobetasol 0.05% nanoemulsion Rx

    SVT-15473 is the first strongest ophthalmic corticosteroid formulated in nanoemulsion (nanodroplets below ~30nm), using IMPACT-SVT®, a patented drug delivery technology, and in single-dose vials, using Blow-Fill-Seal technology packaging.

    SVT-15473 has&nbs...
  • Clotic®- Otic Fungal Infection - Otic Rx

    Product Clotic®- Otic Fungal Infection - Otic Rx

    Clotic® is a broad-spectrum otic antimycotic agent effective against pathogenic dermatophytes, yeasts and several species of fungus, Well-recognized safety and efficacy.
    The first and only treatment with clinical evidence against otomycosis. Preservative-free.

    Indication: Otic fu...
  • Ophthalmic CDMO Services

    Product Ophthalmic CDMO Services

    Salvat can provide the best solutions, based on a long history of expertise in developing and manufacturing successful medications
    • Tailored solutions to customer needs through its Ophthalmic platform. • Specific solutions using Salvat's technology: suspensions, solutions, micellar, and n...
  • Contract Development & Manufacturing Services (CDMO)

    Product Contract Development & Manufacturing Services (CDMO)

    Over 65 years of experience in developing & manufacturing pharmaceutical products for different markets. Operational Excellence, Flexibility & Adaptability.
    Salvat offers integrated CDMO services. We have 3 manufacturing facilities in Barcelona, Madrid, and Miami with the capacity to ...
  • Blow-Fill-Seal Technology (BFS)  Single-dose vials CDMO

    Product Blow-Fill-Seal Technology (BFS) Single-dose vials CDMO

    Salvat specialize in developing and manufacturing sterile liquid pharmaceutical products in single-dose vials, using Blow-Fill-Seal technology (BFS). 

    Advantages of using Blow-Fill-Seal technology in your products: 
    • Innovation in the format, giving differentiation to your produc...
  • Bimeox® 0.3mg/ml - Glaucoma (Preservative-free) - Rx

    Product Bimeox® 0.3mg/ml - Glaucoma (Preservative-free) - Rx

    Bimeox® Bimatoprost 0.3 mg/ml, a well-known prostaglandin analogue eye drop, preservative-free, presented in single-dose vials using our Blow-Fill-Seal Technology.

    • Innovative format in single-dose vials • Preservative-free for better tolerability • Sterile until ope...
  • Tanolux® 50 ug/ml - Glaucoma - Rx

    Product Tanolux® 50 ug/ml - Glaucoma - Rx

    Tanolux® Latanoprost 50 ug/ml, a well-known prostaglandin analogue eye drop, presented in single-dose vials using our Blow-Fill-Seal Technology.

    • Innovative format in single-dose vials • No cold chain required, easy to store & carry • Vey low solvents concentration vs ...
  • Tebarat 0.5 mg/ml - Allergic conjunctivitis - single-dose vials eye drops - Rx

    Product Tebarat 0.5 mg/ml - Allergic conjunctivitis - single-dose vials eye drops - Rx

    Tebarat 0.5 mg/ml eye drops are indicated for the treatment and prevention of allergic conjunctivitis. Treatment and prevention of seasonal allergic conjunctivitis symptoms in adults and children aged 4 years and over.Treatment of non-seasonal (perennial) allergic conjunctivitis symptoms in adults and chil...
  • Relive® Sicca - Dry eye - Nanoemulsion eye drops - MD

    Product Relive® Sicca - Dry eye - Nanoemulsion eye drops - MD

    Symptomatic relief of moderate to severe dry eye syndrome, using IMPACT-SVT® nanoemulsion patent drug delivery technology. 

    Holistic approach for a multi-factorial pathology: anti-inflammatory, antioxidant, mucogenic, mucoadhesion, lubrication, and anti-evaporative activity. •...
  • Relive® Total Care - Lubrication + UV protection eye drops - MD

    Product Relive® Total Care - Lubrication + UV protection eye drops - MD

    Regenerate, protect against UV radiation, and lubricate. Eye tears, specially designed for after surgery.
    • 20 unit dose vials of 0,4 ml • Preservative free • With Actinoquinol 0,3%, Cyanocobalamin 0,05%, PVPK 30 1,5% 
  • Relive® - Day & Night eye drops - MD

    Product Relive® - Day & Night eye drops - MD

    RELIVE® DRY EYE - 8 Hours of Dry Eye Relief
    RELIVE® NIGHT - 12 Hours of Long-lasting Dry Eye Relief • Preservative-Free • Phosphate-Free • Single-dose vials, very Convenient format
  • Cetraxal® Plus 3mg/ml + 0.25 mg/ml - AOE & AOMT - Otic solution Rx

    Product Cetraxal® Plus 3mg/ml + 0.25 mg/ml - AOE & AOMT - Otic solution Rx

    Unique combination "ciprofloxacin 3 mg + Fluocinolone 0.25 mg" topical solution 

    Indication: Acute otitis externa and acute otitis media with perforated eardrums in adults and pediatric patients. 
    Dosage regimen: B.I.D x 7 days
    Presentation of multi-dose 10 ml and unit dose vials (14...
  • Ekzem® 0.25 mg/ml - Otic eczema - single-dose vials - otic solution Rx

    Product Ekzem® 0.25 mg/ml - Otic eczema - single-dose vials - otic solution Rx

    Fluocinolone acetonide, topical solution. Ekzem is indicated for the treatment of otic eczema in adults. Demonstrated efficacy and safety in clinical studies 
    Available in unit dose vials of 0.4 ml each. (30 vials x box)
  • Cristalmina® - Antiseptic - OTC

    Product Cristalmina® - Antiseptic - OTC

    Chlorhexidine digluconate 1% Cristalmina®, offers a quick action and long-lasting effect.
    Cristalmina®, the antiseptic leader in the Spanish market, is the most complete, for the whole family 

    Indication: Minor skin wounds and burns, even for the umbilical cord in newborns.
  • Cetraxal® Otico 2mg/ml - AOE - Otic solution Rx

    Product Cetraxal® Otico 2mg/ml - AOE - Otic solution Rx

    Ciprofloxacin 3 mg, topical solution. 

    Indication: AOE 
    Dosage:  B.I.D x 7 days.
    Presentation: Available in multidose 10ml  and unit dose vials (15 vials).

Laboratorios Salvat, S.A. Resources (4)

  • Video SVT-15473 + IMPACT-SVT® Nanoemulsion technology

    Salvat has developed IMPACT-SVT®, a patented nanoemulsion drug delivery technology that improves drug mucus penetration and bio-adhesion, providing excellent ocular comfort.

    IMPACT-SVT® made it possible to develop SVT-15473, using the strongest corticosteroid in the global market.

  • Brochure Cristalmina® - Topical antiseptic

    Cristalmina®, offers a quick action and long-lasting effect. 
    Indicated in the disinfection of burns and superficial wounds; even for the umbilical cord in newborns.

    Chlorhexidine is the antiseptic of reference, widely recommended in different clinical guidelines.

    Licensing opportunity: Cristalmina®, 10 mg/ml, cutaneous spray solution in 25 ml & 125 ml.
  • Brochure CDMO Services

    Salvat offers an integrated End-to-Endsolution, to ensure your project’s commercial success. We offer the latest technologies withoptimum quality, flexibility andoperational excellence. With over 65years of experience, we can provide theservices and solutions that make ourpartners successful.
  • Brochure Licensing product list

    Sharing a commitmentto patients worldwide

    LICENSING-OUT our products focuson Ophthalmology, Otorhinolaryngology,Gastroenterology & Consumer Health Care.


    LICENSING-IN products for the Spanish,Portuguese, African and Central Americamarkets. Our areas of interest are in Rx productsat Ophthalmology, Otorhinolaryngology andGastroenterology.